Join us for a one-day continuing education meeting that will address the latest strategies and state-of-the art approaches for managing patients with multiple myeloma and other plasma cell disorders. The aim of AMMS is to delve into the latest literature and clinical trial data; to evaluate practice guidelines; to help make sense of the breadth of the information; and to better understand which treatment options are most impactful to the patient. The new two-hour patient program will commence with a presentation from a survivor of multiple myeloma and will also include presentations from our expert faculty in a straightforward and manageable format.

Website

https://web.cvent.com/event/2ca289af-0c46-40fe-be38-a9e19ce99f2d/summary